Giao dịch Bristol Myers BMY

BristolMyers biểu đồ trực tiếp

Kiến thức cơ bản về công cụ

Weekly Search
Weekly
Daily
Ngày Đóng Thay đổi % Thay đổi Mở Cao Thấp

BristolMyers news

Magnificent 7 earnings, US and Japan inflation due next week
Neil Wilson 2024 Jul 18, 16:00

Week ahead: Magnificent 7 earnings, 2 key inflation reports

Forex Indices
Wall Street earnings
Neil Wilson 2023 Oct 20, 10:00

Week ahead: Earnings bonanza, ECB decision & US inflation

Forex Indices
Megacap-tech-stocks.jpg
Neil Wilson 2023 Apr 21, 05:00

Week ahead: Megacap tech and 1-in-3 Dow components set to report

2022 Jul 24, 05:42

Week ahead: Fed to hike 100bps into a recession?

Tin tức mới nhất

Cho xem nhiều hơn
Emma Rose 2025 Sep 12, 09:20

Goldman Sachs, UBS Raise Gold Price Forecasts for 2025

Noah Lee 2025 Sep 12, 09:20

Albania Appoints AI Minister to Combat Corruption in Public Procurement

Emma Rose 2025 Sep 11, 15:20

Dalio: Gold as a Hedge Against Mounting Debt Risks

Ava Grace 2025 Sep 11, 14:20

Switzerland Proposes US Gold Refinery to Reduce Tariffs

Noah Lee 2025 Sep 11, 14:20

NATO and EU on Edge After Russian Drone Enters Poland: A Critical Test

Liam James 2025 Sep 11, 10:20

Economists Anticipate BOJ Rate Hike in Q4 Amidst Global Uncertainties

Sophia Claire 2025 Sep 11, 10:20

Fed Rate Cut Debate Intensifies: Employment Data Revision Fuels Calls for Action

Ava Grace 2025 Sep 11, 10:20

Vietnam to Launch Online Gold Exchange, Allows Imports After Decade

Thông tin

Chênh lệch

0.29

Tỷ lệ Spread (%)

0.6119 %

Đòn bẩy

1:10

Lãi suất Qua đêm Mua

-0.0597 %

Lãi suất Qua đêm Bán

-0.0292 %

Forex

USD

Giờ giao dịch

Thị trường đã đóng cửa.

Thứ sáu

13:31 - 19:59

Thứ hai

13:31-19:59

Thứ ba

13:31-19:59

Thứ tư

13:31-19:59

Thứ năm

13:31-19:59

Phân tích và thống kê

Mở

---

Đóng trước đó

---

52 Tuần Cao/Thấp

--- – ---

Giá trị vốn hóa thị trường

96764821504

Cổ phiếu nổi bật

2035440000

Ngày báo cáo thu nhập (tiếp theo)

2001-08-07

Tỷ suất cổ tức

2025-08-01

Ngày giao dịch không hưởng quyền

2025-07-03

Tỷ lệ cổ tức thường niên kỳ hạn

2.48

Tỷ suất cổ tức thường niên kỳ hạn

0.0526

EPS

2.49

Tìm hiểu thêm về công cụ này

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Các công cụ liên quan

Các công cụ liên quan

latest_education_articles

Cho xem nhiều hơn
Trustpilot